Bock Gerlies, Chittilapilly Elizabeth, Basu Rita, Toffolo Gianna, Cobelli Claudio, Chandramouli Visvanathan, Landau Bernard R, Rizza Robert A
Division of Endocrinology, Diabetes, Metabolism & Nutrition, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Diabetes. 2007 Jun;56(6):1703-11. doi: 10.2337/db06-1776. Epub 2007 Mar 23.
To determine the contribution of hepatic insulin resistance to the pathogenesis of impaired fasting glucose (IFG).
Endogenous glucose production (EGP) and glucose disposal were measured in 31 subjects with IFG and 28 subjects with normal fasting glucose (NFG) after an overnight fast and during a clamp when endogenous secretion was inhibited with somatostatin and insulin infused at rates that approximated portal insulin concentrations present in IFG subjects after an overnight fast (approximately 80 pmol/l, "preprandial") or within 30 min of eating (approximately 300 pmol/l, "prandial").
Despite higher (P < 0.001) insulin and C-peptide concentrations and visceral fat (P < 0.05), fasting EGP and glucose disposal did not differ between IFG and NFG subjects, implying hepatic and extrahepatic insulin resistance. This was confirmed during preprandial insulin infusion when glucose disposal was lower (P < 0.05) and EGP higher (P < 0.05) in IFG than in NFG subjects. Higher EGP was due to increased (P < 0.05) rates of gluconeogenesis in IFG. EGP was comparably suppressed in IFG and NFG groups during prandial insulin infusion, indicating that hepatic insulin resistance was mild. Glucose disposal remained lower (P < 0.01) in IFG than in NFG subjects.
Hepatic and extrahepatic insulin resistance contribute to fasting hyperglycemia in IFG with the former being due at least in part to impaired insulin-induced suppression of gluconeogenesis. However, since hepatic insulin resistance is mild and near-maximal suppression of EGP occurs at portal insulin concentrations typically present in IFG subjects within 30 min of eating, extrahepatic (but not hepatic) insulin resistance coupled with accompanying defects in insulin secretion is the primary cause of postprandial hyperglycemia.
确定肝脏胰岛素抵抗在空腹血糖受损(IFG)发病机制中的作用。
对31例IFG受试者和28例空腹血糖正常(NFG)受试者进行研究,在禁食过夜后以及通过生长抑素抑制内源性分泌且以接近IFG受试者禁食过夜后(约80 pmol/L,“餐前”)或进食后30分钟内(约300 pmol/L,“餐后”)门静脉胰岛素浓度的速率输注胰岛素的钳夹试验期间,测量内源性葡萄糖生成(EGP)和葡萄糖处置情况。
尽管IFG受试者的胰岛素和C肽浓度以及内脏脂肪更高(P < 0.001和P < 0.05),但IFG和NFG受试者的空腹EGP和葡萄糖处置并无差异,这意味着肝脏和肝脏外胰岛素抵抗。在餐前胰岛素输注期间得到证实,此时IFG受试者的葡萄糖处置较低(P < 0.05)而EGP较高(P < 0.05)。较高的EGP是由于IFG中糖异生速率增加(P < 0.05)。在餐后胰岛素输注期间,IFG组和NFG组的EGP受到类似抑制,表明肝脏胰岛素抵抗较轻。IFG受试者的葡萄糖处置仍低于NFG受试者(P < 0.01)。
肝脏和肝脏外胰岛素抵抗导致IFG患者空腹血糖升高,前者至少部分归因于胰岛素诱导的糖异生抑制受损。然而,由于肝脏胰岛素抵抗较轻且在IFG受试者进食后30分钟内通常存在的门静脉胰岛素浓度下EGP接近最大程度抑制,肝脏外(而非肝脏)胰岛素抵抗以及伴随的胰岛素分泌缺陷是餐后高血糖的主要原因。